Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
article has not abstract
Vyšlo v časopise:
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e32767. doi:10.1371/journal.pmed.1000097
Kategorie:
Guidelines and Guidance
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000097
Souhrn
article has not abstract
Zdroje
1. OxmanAD
CookDJ
GuyattGH
1994 Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA 272 1367 1371
2. SwinglerGH
VolminkJ
IoannidisJP
2003 Number of published systematic reviews and global burden of disease: Database analysis. BMJ 327 1083 1084
3. Canadian Institutes of Health Research 2006 Randomized controlled trials registration/application checklist (12/2006). Available: http://www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf. Accessed 19 May 2009
4. YoungC
HortonR
2005 Putting clinical trials into context. Lancet 366 107
5. MulrowCD
1987 The medical review article: State of the science. Ann Intern Med 106 485 488
6. SacksHS
BerrierJ
ReitmanD
Ancona-BerkVA
ChalmersTC
1987 Meta-analysis of randomized controlled trials. New Engl J Med 316 450 455
7. SacksHS
ReitmanD
PaganoD
KupelnickB
1996 Meta-analysis: An update. Mt Sinai J Med 63 216 224
8. MoherD
CookDJ
EastwoodS
OlkinI
RennieD
1994 Improving the quality of reporting of meta-analysis of randomized controlled trials: The QUOROM statement. Lancet 354 1896 1900
9. GreenS
HigginsJ
2005 Glossary. Cochrane handbook for systematic reviews of interventions 4.2.5. The Cochrane Collaboration. Available: http://www.cochrane.org/resources/glossary.htm. Accessed 19 May 2009
10. StrechD
TilburtJ
2008 Value judgments in the analysis and synthesis of evidence. J Clin Epidemiol 61 521 524
11. MoherD
TsertsvadzeA
2006 Systematic reviews: When is an update an update? Lancet 367 881 883
12. University of York 2009 Centre for Reviews and Dissemination. Available: http://www.york.ac.uk/inst/crd/. Accessed 19 May 2009
13. The Joanna Briggs Institute 2008 Protocols & work in progress. Available: http://www.joannabriggs.edu.au/pubs/systematic_reviews_prot.php. Accessed 19 May 2009
14. De AngelisC
DrazanJM
FrizelleFA
HaugC
HoeyJ
2004 Clinical trial registration: A statement from the International Committee of Medical Journal Editors. CMAJ 171 606 607
15. WhittingtonCJ
KendallT
FonagyP
CottrellD
CotgroveA
2004 Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet 363 1341 1345
16. BagshawSM
McAlisterFA
MannsBJ
GhaliWA
2006 Acetylcysteine in the prevention of contrast-induced nephropathy: A case study of the pitfalls in the evolution of evidence. Arch Intern Med 166 161 166
17. Biondi-ZoccaiGG
LotrionteM
AbbateA
TestaL
RemigiE
2006 Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study. BMJ 332 202 209
18. LiberatiA
AltmanDG
TetzlaffJ
MulrowC
GøtzscheP
2009 The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 6 e1000100 doi:10.1371/journal.pmed.1000100
19. AltmanDG
SchulzKR
MoherD
EggerM
DavidoffF
2001 The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134 663 694
20. BossuytPM
ReitsmaJB
BrunsDE
GatsonisCA
GlasziouPP
2003 Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD explanation and elaboration. Ann Intern Med 138 W1 W12
21. VandenbrouckeJP
von ElmE
AltmanDG
GøtzschePC
MulrowCD
2007 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Ann Intern Med 147 W163 W194
22. MoherD
TetzlaffJ
TriccoAC
SampsonM
AltmanDG
2007 Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4 e78 doi:10.1371/journal.pmed.0040078
23. BhandariM
MorrowF
KulkarniAV
TornettaP
2001 Meta-analyses in orthopaedic surgery: A systematic review of their methodologies. J Bone Joint Surg Am 83-A 15 24
24. KellyKD
TraversA
DorganM
SlaterL
RoweBH
2001 Evaluating the quality of systematic reviews in the emergency medicine literature. Ann Emerg Med 38 518 526
25. RichardsD
2004 The quality of systematic reviews in dentistry. Evid Based Dent 5 17
26. ChoiPT
HalpernSH
MalikN
JadadAR
TramerMR
2001 Examining the evidence in anesthesia literature: A critical appraisal of systematic reviews. Anesth Analg 92 700 709
27. DelaneyA
BagshawSM
FerlandA
MannsB
LauplandKB
2005 A systematic evaluation of the quality of meta-analyses in the critical care literature. Crit Care 9 R575 R582
28. DickersinK
2005 Publication bias: Recognizing the problem, understanding its origins and scope, and preventing harm.
RothsteinHR
SuttonAJ
BorensteinM
Publication bias in meta-analysis-Prevention, assessment and adjustments Chichester (UK) John Wiley & Sons 11 33
29. SuttonAJ
2005 Evidence concerning the consequences of publication and related biases.
RothsteinHR
SuttonAJ
BorensteinM
Publication bias in meta-analysis-Prevention, assessment and adjustments Chichester (UK) John Wiley & Sons 175 192
30. LauJ
IoannidisJP
TerrinN
SchmidCH
OlkinI
2006 The case of the misleading funnel plot. BMJ 333 597 600
31. LadabaumU
ChopraCL
HuangG
ScheimanJM
ChernewME
2001 Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: A cost-effectiveness analysis. Ann Intern Med 135 769 781
32. DeeksJJ
2001 Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323 157 162
33. AltmanDG
2001 Systematic reviews of evaluations of prognostic variables. BMJ 323 224 228
34. IoannidisJP
NtzaniEE
TrikalinosTA
Contopoulos-IoannidisDG
2001 Replication validity of genetic association studies. Nat Genet 29 306 309
35. LavisJ
DaviesH
OxmanA
DenisJ
Golden-BiddleK
2005 Towards systematic reviews that inform health care management and policy-making. J Health Serv Res Policy 10 35 48
36. StewartLA
ClarkeMJ
1995 Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med 14 2057 2079
37. MojaLP
TelaroE
D'AmicoR
MoschettiI
CoeL
2005 Assessment of methodological quality of primary studies by systematic reviews: Results of the metaquality cross sectional study. BMJ 330 1053 1055
38. GuyattGH
OxmanAD
VistGE
KunzR
Falck-YtterY
2008 GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 924 926
39. SchunemannHJ
JaeschkeR
CookDJ
BriaWF
El-SolhAA
2006 An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 174 605 614
40. ChanAW
HrobjartssonA
HaahrMT
GøtzschePC
AltmanDG
2004 Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 291 2457 2465
41. ChanAW
Krleza-JericK
SchmidI
AltmanDG
2004 Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 171 735 740
42. SilagyCA
MiddletonP
HopewellS
2002 Publishing protocols of systematic reviews: Comparing what was done to what was planned. JAMA 287 2831 2834
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2009 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- The US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases
- Ethics Without Borders